Squarepoint
PAVM icon

Squarepoint’s PAVmed PAVM Stock Holding History

Squarepoint’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-24
Closed -$10K – 3315
2022
Q2 		$10K Buy
+24
New +$11.6K ﹤0.01% 2792
2022
Q1 		– Sell
-221
Closed -$245K – 3344
2021
Q4 		$245K Buy
+221
New +$480K ﹤0.01% 2570
2021
Q3 		– Sell
-78
Closed -$224K – 3296
2021
Q2 		$224K Buy
+78
New +$184K ﹤0.01% 2738
2020
Q4 		– Sell
-65
Closed -$52K – 3176
2020
Q3 		$52K Buy
65
+42
+183% +$37.4K ﹤0.01% 2364
2020
Q2 		$22K Buy
+23
New +$23K ﹤0.01% 2150

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Squarepoint's PAVM Position: Q3 2022 in Review

Squarepoint sold out of PAVmed (PAVM) in Q3 2022, closing a stake of 24 shares — an estimated $10K sold.

Squarepoint first reported a position in PAVM in Q2 2020 and held it in 5 quarters. The position peaked at $245K in Q4 2021. 70 funds tracked by Wall St. Rank hold PAVM as of Q3 2022.

  • Squarepoint reported no remaining PAVmed position as of Q3 2022 after selling out during the quarter.
  • Squarepoint sold 24 PAVmed shares in Q3 2022, an estimated $10K.
  • Squarepoint first reported a position in PAVmed in Q2 2020 and held it in 5 quarters.
  • Squarepoint's PAVmed position peaked at $245K in Q4 2021.
  • 70 funds tracked by Wall St. Rank held PAVmed as of Q3 2022.

Based on Squarepoint's 13F filing for Q3 2022, filed 14 Nov 2022.